Abivax SA

Forecast & Rating11 analysts currently cover Abivax SA, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $165.91, about 30.8% upside from the current price of $126.87. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 61.4% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Abivax SA closely still see room for the stock to rise. Data as of Jul 24, 2026; for reference only and not investment advice.